XML 33 R21.htm IDEA: XBRL DOCUMENT v3.25.3
Organization and Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Accounts Receivables

Accounts receivable consist of the following:

 

   September 30, 2025   December 31, 2024 
   (Unaudited)   (Audited) 
Billed receivable  $211,459   $173,993 
Unbilled receivable   705,115    63,034 
Accounts receivable  $916,574   $237,027 
Schedule of Accounts Payable

Accounts payable consist of the following:

 

   September 30, 2025   December 31, 2024 
    (Unaudited)    (Audited) 
Research and development expenses  $705,834   $340,698 
Legal expenses   437,558    68,420 
Other   65,018    73,202 
Accounts payable  $1,208,410   $482,320 
Schedule of Accrued Expenses

Accrued expenses consist of the following:

 

   September 30, 2025   December 31, 2024 
    (Unaudited)    (Audited) 
Employee wages and benefits  $486,981   $496,906 
Research and development expenses   825,383    437,196 
Legal expenses   25,000    25,000 
Other   35,000    11,360 
Accrued expenses  $1,372,364   $970,462 
Schedule of Research and Development Costs

Research and development costs consist of personnel-related costs, facilities, research-related overhead, services from independent contract research organizations, and other external costs. Research and development costs, including related party, for the three and nine months ended September 30, 2025 and 2024 were as follows:

 

   2025   2024   2025   2024 
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2025   2024   2025   2024 
   (Unaudited)   (Unaudited)   (Unaudited)   (Unaudited) 
Outside contracted services  $514,886   $336,068   $1,357,727   $1,119,502 
Personnel related costs   

56,986

    121,081    303,371    334,297 
Facilities, overhead and other   

    

3,092

    35,132    

44,794

 
Research and development costs  $571,872   $460,241   $1,696,230   $1,498,593